Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention: No intervention

Study summary

Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population.

In 5-40% of cases, genetic factors are identified as the cause of these disorders.

Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date.

Primary Objective and Endpoint Primary Objective:

Exploration of phenotypic heterogeneity in patients with ASD.

Primary endpoint:

* Routine Care Clinical Investigation Criteria.
* Scores on assessment scales,

Eligibility

Primary outcome measure(s)

• The main objective is to better understand the phenotypic heterogeneity of Autism Spectrum Disorder (ASD). — 12 months
  DSM5 (Diagnostic statistical Manual of Mental disorders) Autism diagnostic scales

Trial sites (1)

More Assistance Publique - Hôpitaux de Paris trials in France

Other trials for the same condition